*CHUN-YU LIN^1,2, Tsung-Ping Su⁴, Shao-Ming Wang^2,3 (1. School of Medicine, China Medical University, Taichung, Taiwan, 2. Neuroscience and Brain Disease Center, China Medical University, Taichung, Taiwan, 3. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 4. Cellular Pathobiology Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland 21224, USA)

*Hibiki Yamazaki¹, Hakushun Sakairi¹, Yoshie Hashimoto¹, Takashi Sakurai¹, Yuji Kamikubo¹ (1. Dept. of Pharmacology, Juntendo Univ. Sch. of Medicine, Tokyo, Japan)